We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.50 | 0.09% | 1,671.50 | 1,671.00 | 1,671.50 | 1,679.50 | 1,658.50 | 1,661.50 | 1,087,128 | 11:26:37 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.95 | 68.73B |
Date | Subject | Author | Discuss |
---|---|---|---|
14/12/2017 18:35 | buywell3 You have cheered me up no end... | 2hoggy | |
14/12/2017 18:10 | Around 1 in every 1500 people alive in the UK are CJD carriers Prion disease is CJD It takes decades to activate in most cases In some cases gene dependent , it can activate sooner In some cases it never activates Nearly 35% of people that are carriers will activate IF they live long enough ie over 85 plus Prion Protein Disease is the root cause of Alzheimer's , Huntingdon's, Parkinsons, Dementia and others Prion-like Behavior in the Huntingtin Protein By ocords 06 May, 2015 Protein Aggregation Prion-Like Behavior in the Huntingtin Protein: Protein aggregates are a hallmark feature of Huntington’s disease (HD)[1], as well as a number of other neurodegenerative diseases. These protein aggregates, composed of misfolded proteins that clump together, are traditionally thought to develop in vulnerable neurons individually. However, recent research suggests that these misfolded proteins may be transmitted from neuron to neuron. Is Parkinson’s A Prion Disease? By Neuroskeptic | October 14, 2017 The Journal of Neuroscience recently featured a debate over the hypothesis that Parkinson’s disease is, at least in some cases, caused by a prion-like mechanism – misfolded proteins that spread from neuron to neuron. Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways. Ayers JI1, Fromholt SE2, O'Neal VM2, Diamond JH2, Borchelt DR2,3. A hallmark feature of amyotrophic lateral sclerosis (ALS) is that symptoms appear to spread along neuroanatomical pathways to engulf the motor nervous system, suggesting a propagative toxic entity could be involved in disease pathogenesis. Are Prions behind All Neurodegenerative Diseases? Evidence mounts that chain reactions involving toxic proteins link Creutzfeldt–Ja | buywell3 | |
14/12/2017 17:37 | 'GSK Applies for Australian Approval of Malaria Treatment' ....Getting the green light in Australia would open the way for approval in countries where the disease is endemic, said GSK, adding that it intends to make the treatment available at a not-for-profit price in such places | philanderer | |
14/12/2017 16:56 | Usual suspects are back. Time to repurchase. | woodhawk | |
14/12/2017 16:43 | Maybe next stop £12.50 ! | abdullla | |
14/12/2017 16:07 | Struggling... Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs | philanderer | |
14/12/2017 13:10 | The noun is advice. Advise is a verb. Please fit that into your busy schedule. | barony | |
14/12/2017 09:16 | Mani - I wonder if that applies to cryptos too? | alphorn | |
13/12/2017 22:49 | Sicker, ttg100, Thanks for the encouragement. The most important piece of advice I can give to all types of traders (scalpeRs, day traders, position traders, investors) is NEVER fight the trend ! (no matter what timeframe you use) The trend is the ONLY reason you can make money out of the markets. There is a strong underlying mathematically based philosophy supporting that view which I would like to share with you all, but that would lead to a wider discussion, which I cannot commit to at this stage. | mani2013 | |
13/12/2017 20:20 | 13th Dec'17:-"GlaxoSmithK | fangorn2 | |
13/12/2017 16:07 | >>GlaxoSmithKl Easy for you to say ;-) | zho | |
13/12/2017 15:46 | Is that news bad,why the rut? | abdullla | |
13/12/2017 14:20 | GlaxoSmithKline PLC (GSK.LN) said on Tuesday that its drug Nucala has been given approval by the Food and Drug Administration for the treatment of eosinophilic granulomatosis with polyangiitis, previously known as Churg-Strauss syndrome, in the U.S. Nucala was first approved in 2015 for severe eosinophilic asthma and the company submitted a supplemental application in June 2017, to expand the use of the medicine. The company said that the FDA's approval is based on results from a 52-week, phase 3 study which was conducted as a collaboration between GlaxoSmithKline and the National Institute of Allergy and Infectious Diseases. | tradermichael | |
13/12/2017 13:47 | mani - keep posting m8 - they are all useful whether long or short | ttg100 | |
13/12/2017 09:11 | Many thanks mani :-) | sicker | |
13/12/2017 08:59 | Woodhawk, I assume you are refering to 15981. It was a more of an addendum rather than an edit. I am a full time day trader. I work from 07:00am to 07:00pm (currency markets after 16:30). I don't have the time to put up a full blown assessment of the movement on the forum like some of you do. It would take too long to explain the price behaviour and justify the thought processes. Trading is all about probabilities. You can't always get it right. That's why you use stop losses. There will more than likely be a pullback towards on the 60m chart towards the 1270 low. If the low holds it will a good sign that the selling pressure on the daily is subsiding and a potential turnaround. It will be a good buying opportunity for long term buyers. If it breaks the low then the downtrend on the Daily continues. It's that simple :) As I write this, I missed a trade on the 5 min chart. I can see why professional traders don't participate on these forums. My main objective of posting here and other forums is to help other market participants, particularly long term buy and hold players, make better decisions at a technical level and not lose money. If you don't want my advice that's fair enough. It's your loss :) | mani2013 | |
13/12/2017 08:28 | mani2013, I see you've now edited your original post to cover your ass. Pathetic. Filtered. | woodhawk | |
13/12/2017 08:16 | Still holding 5000 shares for long term. Good luck to all and let's hope for a better share price in 2018 | mj19 | |
12/12/2017 12:28 | Woodhawk, I always do. Patience is a virtue in the trading game :) | mani2013 | |
12/12/2017 12:24 | Enjoy your wait then, mani2013. | woodhawk | |
12/12/2017 11:45 | I jumped back in here @ 1280p, sold out day before last ex divi date but can't see that happening again now we appear to have a turn round. I also have few IMM from 113p but just a speculative punt because I'm not overly keen on holding AIM companies. | gbh2 | |
12/12/2017 11:08 | Q3 Dividend pays out 11 Jan Q4 Dividend xd date is 22 Feb | tradermichael | |
12/12/2017 10:28 | Not really (IMM) has a very good story so far, all news flow is good, has been seriously undervalued, I started buying 52p, must be worth 250p as it stands, also rare for a small Company they own 100% of Lupuzor, if FDA approval follows, they have fast track already, the upsides are huge on a big pharma take out £20-100+ a share imho. I have absolutely no problems holding that one!! Back to GSK I am holding a very large quantity and happy with quarterly divis, I am sure capital growth will follow. GLA | ny boy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions